Yüklüyor......

Progression of Stargardt Disease as Determined by Fundus Autofluorescence in the Retrospective Progression of Stargardt Disease Study (ProgStar Report No. 9)

IMPORTANCE: Sensitive outcome measures for disease progression are needed for treatment trials of Stargardt disease. OBJECTIVE: To describe the yearly progression rate of atrophic lesions in the retrospective Progression of Stargardt Disease study. DESIGN, SETTING, AND PARTICIPANTS: A multicenter re...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:JAMA Ophthalmol
Asıl Yazarlar: Strauss, Rupert W., Muñoz, Beatriz, Ho, Alexander, Jha, Anamika, Michaelides, Michel, Cideciyan, Artur V., Audo, Isabelle, Birch, David G., Hariri, Amir H., Nittala, Muneeswar G., Sadda, SriniVas, West, Sheila, Scholl, Hendrik P. N.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Medical Association 2017
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5710470/
https://ncbi.nlm.nih.gov/pubmed/29049437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaophthalmol.2017.4152
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!